Press Release: Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024 Conference call and webcast at 8:30am ET CHICAGO--(BUSINESS WIRE)--May 02, 2024-- Xeris Biopharma Holdings, Inc. (Nasda

Dow JonesMay 2 19:00

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Top Owners Are Retail Investors With 51% Stake, While 45% Is Held by Institutions

Yahoo FinanceApr 5 23:15

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business WireApr 4 04:05

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies, today

BusinesswireApr 2 19:00

Xeris Gains as Oppenheimer Highlights Drug Technology

Seeking AlphaMar 29 01:11

Xeris Biopharma Initiated at Outperform by Oppenheimer

Xeris Biopharma Initiated at Outperform by Oppenheimer

Dow JonesMar 28 19:02